National Guideline Clearinghouse | Exenatide prolonged-release suspension for injection in combination with oral antidiabetic therapy for the treatment of type 2 diabetes.

full-text:
National Guideline Clearinghouse | Exenatide prolonged-release suspension for injection in combination with oral antidiabetic therapy for the treatment of type 2 diabetes.

Guideline Title

Exenatide prolonged-release suspension for injection in combination with oral antidiabetic therapy for the treatment of type 2 diabetes.

Bibliographic Source(s)

National Institute for Health and Clinical Excellence (NICE). Exenatide prolonged-release suspension for injection in combination with oral antidiabetic therapy for the treatment of type 2 diabetes. London (UK): National Institute for Health and Clinical Excellence (NICE); 2012 Feb. 45 p. (Technology appraisal guidance; no. 248).

Guideline Status

This is the current release of the guideline.